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Abstract
Butyltins (BTs) contaminate the environment and are found in human blood. BTs, tributyltin
(TBT) and dibutyltin (DBT), diminish the cytotoxic function and levels of key proteins of human
natural killer (NK) cells. NK cells are an initial immune defense against tumors, virally-infected
cells and antibody-coated cells and thus critical to human health. The signaling pathways that
regulate NK cell functions include mitogen-activated protein kinases (MAPKs). Studies have
shown that exposure to BTs leads to the activation of specific MAPKs and MAPK kinases
(MAP2Ks) in human NK cells. MAP2K kinases (MAP3Ks) are upstream activators of MAP2Ks,
which then activate MAPKs. The current study examined if BT-induced activation of MAP3Ks
was responsible for MAP2K and thus, MAPK activation. This study examines the effects of TBT
and DBT on the total levels of two MAP3Ks, c-Raf and ASK1, as well as activating and inhibitory
phosphorylation sites on these MAP3Ks. In addition, the immediate upstream activator of c-Raf,
Ras, was examined for BT-induced alterations. Our results show significant activation of the
MAP3K, c-Raf, in human NK cells within 10 minutes of TBT exposure and the MAP3K, ASK1,
after one hour exposures to TBT. In addition, our results suggest that both TBT and DBT are
impacting the regulation of c-Raf.
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Introduction
Butyltins (BTs) are toxic organotin compounds which contaminate the environment (Hoch,
2001). The BTs tributyltin (TBT) and dibutyltin (DBT) have various commercial
applications (Roper, 1992; Takahashi et al., 1999; Gipperth, 2009). TBT was formerly used
as a marine biocide in antifouling paints to prevent the growth of aquatic organisms on the
hulls and decks of boats and ships (Antizar-Ladislao, 2008; Clark et al., 1988; Fent, 2006;
Hoch, 2001). TBT’s use in marine antifouling paints has been banned since 2008 but it will
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continue to contaminate the environment for many years due to its chemical stability, non-
marine uses, applications to ships prior to the ban, and marine uses in spite of the ban
(Gipperth, 2009) It has also been used as a wood preservative (Antizar-Ladislao, 2008;
Clark et al., 1988; Hoch, 2001). Due to its use as an aquatic pesticide, there are concerns
about its effects on the marine ecosystem (Kannan et al., 1995; Clark et al., 1988). Studies
have shown TBT to be harmful to mammals, including humans, primarily due to
neurotoxicity (Antizar-Ladislao, 2008; Boyer, 1989; Nakanishi et al., 2006; 2007; Saitoh et
al, 2001). Higher order organisms have become accidently contaminated as a result of
leaching of the chemical from the paints into the water and/or the consumption of
contaminated animals (Fent, 2006; Mora et al., 1989; Veltman et al. 2006). Humans can then
be inadvertently exposed to the chemical by ingesting contaminated food (Antizar-Ladislao,
2008; Belfroid et al., 2000; Kannan et al., 1995; Sadiki et al., 1996; Takahashi et al., 1999).
Significant levels of TBT (as high as 261 nM, 85 ng/mL) have been found in human blood
(Whalen et al., 1999; Kannan et al., 1999). Studies have shown that TBT causes thymic
atrophy and thymus dependent immunosuppression in rodents (Snoeij et al., 1987, 1989;
Vos et al. 1990).
DBT is used as a stabilizer of plastics and as a deworming agent in poultry (Epstein et al.,
1991; Kannan et al., 1995; Takahashi et al., 1999). It is commonly found in Polyvinyl
chloride plastics (Sadiki et al., 1996). Human exposure results from the usage of plastic
cooking products containing DBT (Kannan et al., 1995; Takahashi et al., 1999) and/or the
leaching of the chemical into drinking water from plastic water bottles and PVC pipes; as
well as, ingestion of contaminated food (Azenha et al., 2002; Forsyth et al., 1992; 1997;
Kannan et al., 1995; Sadiki et al., 1996; Takahashi et al., 1999). Dibutyltin concentrations
have been detected in the livers of humans and other mammals (Takahashi et al., 1999).
Specifically, DBT has been found at concentrations between 0.8 and 28.3 ng/g in human
livers (Nielsen et al., 2002) and has been found in human blood at levels as high as 300 nM
(94ng/mL) (Whalen et al., 1999; Kannan et al., 1999).
TBT and DBT have been shown to have an immunotoxic effect on human natural killer cells
by significantly decreasing both their cytotoxic function and levels of cytolytic and cell-
surface proteins (Aluoch et al., 2006; Dudimah et al., 2007a,b; Catlin et al., 2005; Odman-
Ghazi et al, 2003; Whalen et al., 2002). Natural killer (NK) cells are part of the innate
immune system, the body’s first defense against foreign invaders. NK cells kill tumor cells,
virally-infected cells, or antibody-coated cells through receptor-mediated activation leading
to the release of the cytotoxic proteins granzyme and perforin (Lowin et al., 1994; Shresta et
al., 1995). NK cells also contribute to adaptive immunity in various manners. NK cells have
recently been shown to stimulate the maturation of dendritic cells (Walzer et al., 2005;
Wehner et al., 2011). Therefore, interference with NK function could render humans
susceptible to the development of primary tumors, blood-borne metastasis, and severe
infections.
An intracellular signaling pathway is activated when a NK cell binds to a target cell (Wei et
al., 1998). This pathway ultimately leads to the activation of mitogen-activated protein
kinases (MAPKs). Their activation results in the lysis of the bound target cell via the final
release of the NK cell’s cytotoxic proteins (Wei et al., 1998). We hypothesize that premature
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activation of this pathway by BTs may interfere with the NK cell’s natural ability to lyse its
target cell by rendering it incapable of triggering this pathway during a subsequent
encounter with a tumor cell or infected cell. Our previous studies have shown a significant
increase in the activation of the MAPKs, p38, p44/42, JNK, and the MAPK Kinases
(MAP2Ks), MKK3/6 and MEK1/2, by TBT within ten minutes of exposure in human NK
cells (Aluoch et al., 2005; 2006; 2007). DBT also induces the activation of p38, p44/42,
MKK3/6, and MEK1/2 after brief exposure in human NK cells (Odman-Ghazi et al., 2010).
The purpose of this study is to investigate whether exposure of human NK cells to TBT and
DBT also result in the activation/phosphorylation of the MAP3Ks, c-Raf and/or ASK-1, in a
Ras-dependent or independent manner. Ras is a GTPase normally involved in the activation
of the MAP3K, c-Raf. In its inactive state, Ras is normally found bound to GDP; but upon
activation, Ras binds GTP. Ras specifically binds to the Ras Binding Domain (RBD) of c-
Raf.
Materials and Methods
Isolation of NK Cells from Human Blood
Highly purified natural killer cells were isolated from buffy coats collected from healthy
adult male and female donors (American Red Cross, Portland, OR; Life blood, Memphis,
TN) using the RosetteSep Human NK Cell Enrichment Antibody Cocktail protocol (Stem
Cell Technologies, Vancouver, BC, Canada) (600 μL of antibody cocktail was added per 40
mL of blood). The mixture was incubated at room temperature 20 minutes. Following the
incubation period, 7–8 mL were layered onto 4 mL of Ficoll-Hypaque (1.077 g/mL). The
mixture was then centrifuged at 1200g for 50 minutes. NK cells were collected and washed
twice with PBS solution and stored in complete media (RPMI-1640 supplemented with 10%
heat-inactivated bovine calf serum (BCS), 2 mM L-glutamine and 50 U penicillin G with 50
μg streptomycin/ml) at 1 million cells/mL at 37 °C and air/CO2, 19:1 (Whalen et al., 2002).
Donors are given numbers based on the source of the buffy coat Red Cross = RC# and Life
blood = LB#.
Chemical Preparation
TBT (Sigma-Aldrich, St. Louis, MO) was dissolved in deionized water to yield a 1mM stock
solution. This solution was then diluted in media to achieve the desired final concentration
of 300, 200, 100, 50 or 25 nM (Whalen et al., 2002). DBT (Sigma-Aldrich) was dissolved in
dimethylsulfoxide (DMSO) to make a stock solution which is diluted to 10, 5, 2.5, 1 and 0.5
μM concentrations in cell culture medium (Aluoch et al., 2005; Odman-Ghazi et al., 2010).
Cell Treatments
Purified NK cells (1.5 million cells/mL) were exposed to (1) no TBT (control), (2) 300 nM
TBT, (3) 200 nM TBT, (4) 100 nM TBT, (5) 50 nM TBT or (6) 25 nM TBT followed by an
incubation period of 10 minutes, 1 hour, or 6 hours at 37°C and 19:1 air/CO2. Purified NK
cells (1.5 million cells/mL) were also exposed to (1) no DBT (control), (2) 10 μM DBT, (3)
5 μM DBT, (4) 2.5 μM DBT, (5) 1 μM DBT or (6) 0.5 μM DBT followed by an incubation
period of 10 minutes, 1 hour or 6 hours at 37°C and 19:1 air/CO2.
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Cell lysates were prepared from NK cells exposed (as described above) using 500 μL of
lysis buffer (Active motif, Carlsbad, CA) per 10 million cells. The cell lysates were stored
frozen at −80°C up to the point when they were run on SDS-PAGE. All controls and TBT-
or DBT-exposed cells for a given experimental set-up were from an individual donor. Each
of the experimental set-ups was repeated a minimum of four times using cells from different
donors.
Western blots
The samples were run on a 10% SDS-PAGE and then transferred to a PVDF membrane. The
PVDF membrane was then immunoblotted with anti-c-Raf1 (total), anti-phospho-c-Raf1
(S338), anti-phospho-c-Raf1 (S259), anti-phospho-c-Raf 1 (S289/296/301) and anti-ASK-1
(total), anti-ASK-1 (S967) and anti-ASK-1 (T845) antibodies (Cell Signaling Technology,
Inc.; Danvers, MA). In addition, anti-β-actin was used to verify that equal amounts of
protein were loaded. Antibodies were visualized using an ECL chemiluminescent detection
system (GE Healthcare; Piscataway, NJ) and a Kodak Image Station 4000R (Rochester,
NY). The density of each protein band was determined using the Kodak Image Station
analysis software. The samples from each experimental condition were run on a separate gel
and blot. Each set of experimental conditions had its own internal control (untreated cells).
Therefore, any observable changes or differences in protein expression were determined
based on the internal control. This determination provides relative quantitation by evaluating
whether a given treatment changed in expression relative to the untreated cells. The density
of each protein band was normalized to β-actin to correct for small differences in protein
loading among the lanes. A minimum of 4 separate experiments were carried out for
analysis (Aluoch et al., 2005; Odman-Ghazi et al., 2010).
ELISA Assays
Activated GTP-Ras was determined by using a Ras Activation Elisa Assay Kit (EMD
Millipore Co., Billerica, MA). NK cell lysates exposed to either C, 300, 200, 100, 50 or 25
nM TBT or C, 10, 5, 2.5, 1 or 0.5 μM DBT concentrations at an exposure time of ten
minutes were assayed for Ras in the GTP bound- activated- form that binds to the Ras
Binding Domain (RBD) of Raf. Activated Ras was detected and measured in the cell lysate
samples, prepared as stated above. The captured activated Ras that binds to the RBD of
Raf-1 was detected using the HRP conjugated secondary antibody provided. After adding
the chemiluminescent substrate, the intensity of the signal was measured using a
luminometer (Fluoroskan Ascent FL, Thermo Fisher, Pittsburgh, PA). Each experimental
condition had its own internal control (untreated cells).
Statistical Analysis
Statistical analysis were determined using ANOVA and Student t-test; significance being a
p-value<0.05. At least 4 separate experiments were carried out for analysis of each
experimental condition.
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The effect of 10 minute exposures to 300, 200 100, 50 and 25 nM TBT on activation state of
Ras in human NK cells
Activated Ras was determined in NK cells exposed for 10 min to Control (no TBT), 300,
200, 100, 50 and 25 nM TBT. Data are presented as percent of the control (Figure 1). A
significant 10 to 15 percent decrease from the control was observed at the 300, 200, 100 and
50 nM exposures; specifically, a 10% decrease at the 300 nM concentration, 11% at 200
nM, 14% at 100 nM and 15% at the 50 nM concentration (Figure 1).
The effect of 10 minute exposures to 10, 5, 2.5, 1 and 0.5 μM DBT on the activation state of
Ras in human NK cells
When NK cells were exposed to DBT for 10 min, there was a significant 10 to 20% decrease
in the amount of activated GTP-Ras compared to the control at the 10, 5 and 2.5 μM
concentrations. The 10 μM concentration resulted in a 12% decrease, the 5 μM in an 18%
decrease and the 2.5 μM in a 12% decrease from the control (Figure 2).
The effect of 10 minute exposures to 300, 200, 100, 50, and 25 nM TBT on the
phosphorylation state of c-Raf and ASK1 in human NK cells
Four c-Raf antibodies were used: c-Raf (total protein levels), S338 (activation
phosphorylation site), S259 (inhibitory phosphorylation site) and S289/296/301(feedback
inhibition sites). There was a significant increase of total c-Raf (2.3 fold) at the 200 nM
concentration and 1.5 at the 100 nM concentration of TBT (Figure 3A and B). Although not
statistically significant, due to donor variability, four out of 5 donors showed an increase in
phosphorylation at both the 300 and 50 nM concentrations; ranging from 1.2–2.8 fold at the
300 nM concentration and 1.2–4.3 fold at the 50 nM concentration. In addition, three out of
five donors showed an increase varying from 1.4 to 3.7 fold for total c-Raf at the 25 nM
concentration. Increased activation/phosphorylation of c-Raf at S338 was seen with
exposures to 300, 200, 100, and 50 nM of TBT (2 fold at 300-100 nM and 1.45 fold at 50
nM) when compared to the control (Figure 3C and D). Elevated expression levels of S259
were also observed at the 300-200 nM (2 and 1.7 fold, respectively) (Figure 3E and F).
While statistically insignificant, each of the four donors showed an increase in
phosphorylation of S259 at the 100 nM exposure. A 1.8 fold increase was seen for donor
RC684, 3.1 for donor RC694, 3.1 for donor RC708, and 1.5 for donor LB1 (Table 1). Three
of four donors also showed an increase in S259 phosphorylation (1.4 to 2.1 fold) at the 50
nM exposure. Exposures to 300, 200, and 100 nM TBT significantly increased
phosphorylation of Ser289/296/301, 2.5, 2.0, and 2.4 fold, respectively (Figure 3G and H).
Increases for each of the four donors at the 50 nM concentration were also seen without
collectively resulting in statistical significance. A 1.5 fold increase was seen for donor
RC684, 3.4 fold increase for RC694, 2.3 fold increase for RC708 and 1.2 fold increase for
LB1 (Table 1). Ten minute exposures of the human NK cells to these same concentrations of
TBT (300-25 nM) showed no significant changes in the phosphorylation or total levels of
ASK1 (p < 0.05) (Figure 4).
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The effect of 1 hour exposures to 300, 200, 100, 50, and 25 nM TBT on the phosphorylation
state of c-Raf and ASK1 in human NK cells
There was a significant decrease (40%) to 0.6 of the control (1 fold) for total c-Raf at the 25
nM concentration (p<0.05)(Figure 5A and B). A significant 1.7 fold increase in
phosphorylation of S338 (activation) was seen with exposure to 200 nM TBT (Figure 5C
and D) and a 1.45 fold increase for S289/296/301 at 100 nM TBT (p<0.05) (Figure 5E and
F). NK cell exposure to 300 nM of TBT caused an increase in phosphorylation of S338 in 2
out of the 4 donors ranging from 1.4 fold to 1.5 fold (p>0.05). Three out of 4 donors also
showed increases in the levels of phosphorylation of S338 at the 100 and 50 nM
concentrations, ranging from 1.3 to 1.7 at the 100 and 1.2 to 2.2 at the 50 nM concentrations
(p>0.05). Although, the data for c-Raf at S289/296/301 yielded statistically insignificant
results for the 200, 50 and 25 nM TBT exposures, due to variability among donors, 3 out of
4 donors showed an increase at each exposure ranging from 1.2–1.6 at the 200 nM, 1.25–3.0
at the 50 nM and 1.3–1.9 at the 25 nM concentrations. No significant changes were seen for
c-Raf at S259 (Figure 5G).
Exposure to 25 nM TBT for 1 h caused a 2.0 fold increase total ASK1 protein (p<0.05)
(Figure 6a and b). The remaining four TBT concentrations did not show statistically
significant increases in ASK. However, many of the donors showed increases in total ASK1
but there was considerable variation among donors (Table 2). Phosphorylation of ASK1 at
S967 was significantly increased 2.8 fold at the 50 nM concentration and 2.5 fold at the 25
nM concentration, (p<0.05) (Figure 6C and D). Each of the donors showed an increased in
ASK1 S967 phosphorylation at the 300 and 200 nM concentrations, however, the results
were not statistically significant (Table 2). Three out of four donors showed an increase in
S967 phosphorylation at the 100 nM exposure (p>0.05) (Table 2). Phosphorylation of ASK1
T845 was significantly increased at the 50 and 25 nM concentrations, 2.2 fold and 1.6 fold
correspondingly (p<0.05) (Figure 6E and F). Table 2 shows that there were increases in
phosphorylation of ASK1 T845 in 4 of 5 donors at the 300 nM and 25 nM exposures, and all
5 donors at the 100 nM exposure. However, there was a very wide range in the fold increase
among the donors resulting in a p >0.05.
The effect of 6 hour exposures to 300, 200, 100, 50, and 25 nM TBT on the phosphorylation
state of c-Raf and ASK1 in human NK cells
A 1.5 fold increase was observed at the 300 nM concentration for total c-Raf and 1.7 at the
50 nM concentration (p<0.05) (Figure 7A and B). A 1.3 to 2.4 fold increase for total c-Raf
was seen for three out of the four donors at the 100 nM concentration. However, the wide
range in fold increases due to donor variability yielded statistically insignificant results.
Figure 7C depicts representative western blot results showing no significant changes in
phosphorylation for c-Raf at the three amino acid sites or ASK1 in human NK cells after
they were exposed to 300, 200, 100, 50 and 25 nM TBT for 6 hours as compared to control
(no TBT).
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The effect of 10 minute and 1 hour exposures to 10, 5, 2.5, 1 and 0.5 μM DBT on the
phosphorylation state of c-Raf and ASK1 in human NK cells
Examination of total c-Raf in NK cells exposed to DBT for 10 min showed a statistically
significant decrease (43%) only at the lowest (0.5 μM) DBT exposure (Figure 8A and B).
No significant changes in phosphorylation were seen at any of the c-Raf or ASK1 sites with
a 10 min (Figure 8C) or 1 hour (Figure 9) of DBT.
The effect of 6 hour exposures to 10, 5, 2.5, 1 and 0.5 μM DBT at concentrations on the
phosphorylation state of c-Raf and ASK1 in human NK cells after 6 hour exposure
Significant decreases were seen in phosphorylation of c-Raf S259 after 6 h exposures to 10,
5, and 2.5 μM DBT (Figures 10A and B). 10 μM DBT decreased S259 phosphorylation by
63% while 5 μM and 2.5 μM DBT decreased phosphorylation by 77 and 47% respectively.
There were no other significant changes in phosphorylation or total levels for either c-Raf or
ASK1 in human NK cells after 6 h exposures to DBT (Figure 10C).
Discussion
Previous studies have shown a significant increase in the activation of the MAPKs p44/42,
p38 and JNK and the MAP2Ks MKK3/6 and MEK1/2 by TBT within ten minutes of
exposure (Aluoch et al., 2006; 2007). DBT also induces the activation of these same
enzymes at brief exposures (Odman-Ghazi et al., 2010). It has been shown that BT-induced
loss of NK-lytic function and specific cell-surface proteins needed for lytic function can be
attributed to the activation of p44/42 (Dudimah et al., 2010a, b). Additionally, it has been
shown that BT-induced alterations of cell-surface protein expression could be prevented if
MAPK activation was blocked prior to exposure to BTs (Dudimah et al., 2010b). These
results demonstrated the essential role of activation of the MAPK components of the NK
signaling pathway in the BT-induced alterations of human NK cell functions. The current
study examines whether BTs induce activation of the immediate upstream activators of
MAP2Ks, the MAP3Ks. This study specifically examines if TBT and DBT cause the
activation of the MAP3Ks c-Raf (also known as Raf1) and ASK1 in human NK cells; and if
so, if c-Raf activation is due to BT activation of Ras. Highly purified NK cells were exposed
to concentrations of TBT and DBT at which loss of lytic function (Dudimah et al, 2007b;
Whalen et al., 1999) and activation of MAPKs and MAP2Ks were seen (Aluoch et al., 2005;
2006; 2007; Odman-Ghazi et al., 2010). These levels approach those found in human blood
(Kanan et al., 1999; Whalen et al., 1999).
C-Raf is the upstream regulator of the MAP2Ks, MEK 1 and 2, which in turn activate the
MAPKs, p44 and p42. Activated Ras binds to the Ras Binding Domain (RBD) of c-Raf and
recruits the protein to the plasma membrane (Vojtek et al., 1993). Activation of c-Raf is also
dependent on phosphorylation of Serine 338 (S338) (King et a., 1998; Wellbrock et al.,
2004). C-Raf is negatively regulated by phosphorylation of Serine 259 (S259).
Phosphorylated S259 serves a needed part of the binding site for 14-3-3 scaffold/adaptor
proteins that bind to c-Raf. 14-3-3 prevents the association of c-Raf with its immediate
upstream activator Ras-GTP (Matallanas et al., 2011; Molzan et al., 2012). This site is
phosphorylated by Akt/protein kinase B (PKB) (Zimmermann et al., 1999). The
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phosphorylation of Serine 289, 296, and 301 (S289/296/301) in c-Raf are involved in a
negative feedback pathway. The three become hyperphosphorylated in response to the
incessant activation of c-Raf. The three amino acid residues are phosphorylated by the
downstream regulator MAPK. Their phosphorylation decreases the affinity of Ras for c-Raf
(Dougherty et al., 2005).
The MAP3K ASK1 is the immediate upstream regulator of the MAP2Ks, MKK3/6 and
MKK4. MKK3/6 and MKK4 are responsible for activating p38, but only MKK4 activates
JNK (Tobiume et al., 2001). Phosphorylation of threonine 845 (T845) is required for the
activation of ASK1; thus, it is an activation site. Phosphorylation on Serine 967 (S967)
inactivates ASK1. This phosphorylation is necessary for its association with 14-3-3 proteins
(Zhang et al., 1999). ASK1 is activated in response to signals including cellular stress by
dephosphorylation of S967 and phosphorylation of T845 (Zhang et al., 1999).
The significant10–15% decrease of activated GTP-Ras observed in NK cells after their
exposure to TBT (Figure 1) and 10 to 20 % decrease seen in the NK cells after their
exposure to DBT (Figure 2) leads to at least two possible interpretations. First, either
exposure of these cells to BTs does not result in the activation of Ras; indicating that an
alternative method for BT-induced activation of c-Raf exists. Perhaps an alternate method of
activation for c-Raf is via PKC (Abraha et al. 2010) or PAK3 signaling (Corbit et al., 2003;
King et al., 1998). The second possibility is that the activation of Ras occurs immediately
upon exposure to TBT or DBT (in less than 10 minutes) and at 10 minutes it has already
begun to be desensitized and down-regulated. Unfortunately, our techniques do not allow a
measurement earlier than 10 min. The second possibility fits with the fact that each of the
concentrations that show a decrease in activated Ras are ones where downstream
components of the pathway, MEK1/2 and p44/42, are activated by BTs (Aluoch et al., 2006;
Odman-Ghazi et al., 2010).
There was increased phosphorylation of c-Raf at the activating site S338 when NK cells
were exposed to TBT for 10 min. Those concentrations of TBT that caused activation of c-
Raf also showed activation of MEK1/2 and p44/42 (Aluoch et al., 2006). Thus the data from
this study would indicate that the TBT-induced activation of p44/42 seen in previous studies
was due to TBT-induced activation of c-Raf (Figures 3C and D). Increased phosphorylation
of S289/296/301 after 10 minute (Figures 3G and H) and after 1 hour (Figures 5E and F)
exposures also corroborates the activation of c-Raf in TBT-exposed NK cells, since these
sites are part of a negative feedback mechanism that help “shut-down” c-Raf in response to
subsequent activation events (Dougherty et al., 2005). In addition, though not statistically
significant due to donor variability, all of the donors showed an increase in phosphorylation
of c-Raf at S289/296/301 after 10 minute exposure to TBT at the 50 nM concentration
(Table 1) and three out of four donors showed an increase ranging up to 3 fold at the 200, 50
and 25 nM concentrations after NK cell exposure to 1 hour of TBT. The activation of c-Raf
in the NK cells after as little as 10 minute exposure to TBT but no activation after 6 hour
exposure (Figure 7C) implies that c-Raf has already been desensitized by 6 hours.
Activation of c-Raf by TBT would lead to activation of the p44/42 MAPK pathway and
ultimately to its “shut-down.” As this pathway is essential to the normal function of the NK
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cell, its activation by TBT will leave the cell unable to respond to appropriate stimuli such as
tumor cell or virally infected cells (Wei et al., 1998).
In addition to the TBT-induced activation of c-Raf by phosphorylation of S338, the total
amount of c-Raf present within the NK cells was significantly increased at several
concentrations after 10 minute exposures (Figure 3A and B). Although, data from the
remaining three concentrations- 300, 50 and 25 nM- after 10 minute exposure and data from
the 200, 100 and 25 nM concentrations after 6 hour exposure did not yield statistically
significant results, at least three out of the five donors per concentration showed an increase
ranging up to 4.3 fold of total c-Raf after 10 minutes and half of the donors exposed to 6
hours of TBT also showed an increase ranging up to 2.4 fold in the total amount of c-Raf.
As with all human-related studies, there are many factors that contribute to donor variability.
For example, diet, weight, genetic make-up, environment (among other things) can all
contribute to donor variation. The increases seen in the total amount of c-Raf readily
available within the NK cells after their exposure to TBT suggests that c-Raf is being
upregulated in response to the chemical at least in some cases. This may indicate that TBT is
interfering with the normal processes involved in regulating c-Raf synthesis and destruction
either by decreasing or increasing ubiquitination of the protein (Hayes et al, 2012).
Although exposures of NK cells to 300-50 nM TBT caused significant increases in activated
MKK3/6 and p38 after 10 min, there was no activation of the MAP3K for that pathway,
ASK1. This indicates that we may be missing the activation of this MAP3K due to the fact
that the phosphorylation sites that we examined not being the sole mechanism of regulation
of this MAP3K. It may also be that the phosphatases that regulate ASK1 are more active
than those for Raf. In addition, it may be that another MAP3K or mechanism is responsible
for the activation of MKK3/6.
Ten minute, one hour, and six hour exposures of human NK cells to DBT yielded no
significant increases in phosphorylation of either c-Raf or ASK1 (Figures 8C, 9 and 10C).
After only 10 minutes of DBT exposure, there were significant decreases in the amount of
total c-Raf protein levels at the lowest concentration, 25 μM (Figure 8A and B). This
suggests that c-Raf may be down-regulated in response to its prior constant activation, as it
was in the NK cells that were exposed to 1 hour of TBT. This observation also supports the
notion that DBT-induced activation of c-Raf occurs before 10 minutes- i.e. immediately-
and that higher concentrations of DBT have induced a significant down regulation due to a
very fast intense activation. C-Raf activation prior to 10 minutes explains why the enzyme is
unresponsive or desensitized after 10 minute, 1 or 6 hour exposure to DBT (Figures 8C, 9
and 10C). C-Raf’s downregulation, again, could be due to DBT inhibition of c-Raf synthesis
or increase in its destruction.
Significant decreases in phosphorylation of c-Raf at S259 (Figure 10A and B) were seen
after 6 h exposures to DBT. S259 is the site that when phosphorylated causes association of
c-Raf with 14-3-3 and inhibition of c-Raf catalytic activity. The fact that this site is not
being phosphorylated after 6 h exposures to DBT may be due to DBT-induced changes in
levels or catalytic activity of PI3K/Akt signaling pathway. Akt, also known as PKB, is
responsible for phosphorylating S259 and thereby inactivating c-Raf (Zimmermann et al.,
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1999). Therefore, if Akt is being inhibited, for example, it would render it incapable of
phosphorylating c-Raf at S259; hence, the levels of phosphorylated S259 would decrease.
The decreased inhibiton of c-Raf by decreased inhibitory phosphorylation of S259 is
consistent with the fact that after 6 h there is an activation of both MEK1/2 and p44/42 in
DBT exposed cells (Odman-Ghazi et al., 2010).
The MAP3K c-Raf is responsible for activating the MAP2Ks MEK 1 and 2, which in turn
activate the MAPKs p44 and p42. This pathway ultimately leads to the release of the NK
cell’s cytotoxic proteins. ASK1, another MAP3K, activates MKK3/6 (MAP2Ks) which in
turn activate p38 and JNK (MAPKs). This pathway regulates other aspects of NK function
that are important to NK cytotoxic function (Trotta et al., 2000). Previous studies have
shown a significant increase in the activation of the MAPKs, p38, p44/42, JNK, and the
MAP2Ks, MKK3/6 and MEK1/2, by TBT within ten minutes of exposure (Aluoch et al.,
2005; 2006; 2007). DBT also induces the activation of p38 and p44/42 and their respective
MAP2K (Odman-Ghazi et al., 2010). The intent of the current study was to examine if
compound induced activation of MAP3K was responsible for MAP2K and thus, MAPK
activation. Here we show that significant activation of c-Raf in human NK cells also occurs
within 10 minutes of TBT exposure. ASK1 is also being activated after one hour exposure
of human NK cells to TBT. In addition, our total c-Raf results suggest that both TBT and
DBT are impacting regulation of c-Raf.
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Figure 1. Effect of exposures to TBT on the activation state of Ras
NK cells were exposed to 300-25 nM TBT for 10 minutes (Error bars represent average ±
standard deviation from mean, n=4, NK cells prepared from 4 different donors, * represent p
< 0.05).
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Figure 2. Effect of exposures to DBT on the activation state of Ras
NK cells were exposed to 10-0.05 μM of DBT for 10 minutes (Error bars represent average
± standard deviation from mean, given n=4, * represent p < 0.05).
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Figure 3. Effect of 10 min exposures to 300 to 25 nM TBT on c-Raf in human NK cells
A) Levels of total c-Raf shown as fold change compared to control. Values are mean ± S.D.
from 5 separate experiments using cells from different donors *p<0.05. B) Representative
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western blot for total c-Raf. C) Levels of c-Raf phosphorylated at S338 shown as fold
change compared to control. Values are mean ± S.D. from 4 separate experiments using
cells from different donors *p<0.05. D) Representative western blot for c-Raf
phosphorylation at S338. E) Levels of c-Raf phosphorylated at S259 shown as fold change
compared to control. Values are mean ± S.D. from 4 separate experiments using cells from
different donors *p<0.05. F) Representative western blot for c-Raf phosphorylation at S259.
G) Levels of c-Raf phosphorylated at S289/296/301 shown as fold change compared to
control. Values are mean ± S.D. from 4 separate experiments using cells from different
donors *p<0.05. H) Representative western blot for c-Raf phosphorylation at S289/296/301.
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Figure 4. Effect of 10 min exposures to 300 to 25 nM TBT on ASK1 in human NK cells
Representative western blot results showing no significant changes in total ASK1, ASK1
phosphorylation at S967, or ASK1 phosphorylation at T845 after exposure of NK cells to
25–300 nM TBT (n=4, p > 0.05).
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Figure 5. Effect of 1h exposures to 300 to 25 nM TBT on c-Raf in human NK cells
A) Levels of total c-Raf shown as fold change compared to control. Values are mean ± S.D.
from 4 separate experiments using cells from different donors *p<0.05. B) Representative
western blot for total c-Raf. C) Levels of c-Raf phosphorylated at S338 shown as fold
change compared to control. Values are mean ± S.D. from 4 separate experiments using
cells from different donors *p<0.05. D) Representative western blot for c-Raf
phosphorylation at S338. E) Levels of c-Raf phosphorylated at S289/296/301 shown as fold
change compared to control. Values are mean ± S.D. from 4 separate experiments using
cells from different donors *p<0.05. F) Representative western blot for c-Raf
phosphorylation at S289/296/301. G) Representative western blot for c-Raf phosphorylation
at S259.
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Figure 6. Effect of 1 h exposures to 300 to 25 nM TBT on ASK1 in human NK cells
A) Levels of total ASK1 shown as fold change compared to control. Values are mean ± S.D.
from 5 separate experiments using cells from different donors *p<0.05. B) Representative
western blot for total ASK1. C) Levels of ASK1 phosphorylated at S967 shown as fold
change compared to control. Values are mean ± S.D. from 4 separate experiments using
cells from different donors *p<0.05. D) Representative western blot for ASK1
phosphorylation at S967. E) Levels of ASK1 phosphorylated at T845 shown as fold change
compared to control. Values are mean ± S.D. from 5 separate experiments using cells from
different donors *p<0.05. F) Representative western blot for ASK1 phosphorylation at
T845.
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Figure 7. Effect of 6 hour exposures to 300 to 25 nM TBT on c-Raf and ASK1 in human NK cells
A) Levels of total c-Raf shown as fold change compared to control. Values are mean ± S.D.
from 4 separate experiments using cells from different donors *p<0.05. B) Representative
western blot for total c-Raf. C) Representative western blots for c-Raf phosphorylation at
S338, S259, S289/296/301 and for total ASK1 and ASK1 phosphorylation at S967, T845.
Four separate experiments were analyzed using cells from different donors, p>0.05.
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Figure 8. Effect of 10 minute exposures to 10 to 0.5 μM DBT on c-Raf and ASK1 in human NK
cells
A) Levels of total c-Raf shown as fold change compared to control. Values are mean ± S.D.
from 4 separate experiments using cells from different donors *p<0.05. B) Representative
western blot for total c-Raf. C) Representative western blots for c-Raf phosphorylation at
S338, S259, S289/296/301 and for total ASK1 and ASK1 phosphorylation at S967, T845.
Five separate experiments were analyzed using cells from different donors, p>0.05.
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Figure 9. Effect of 1 hour exposures to 10 to 0.5 μM DBT on c-Raf and ASK1 in human NK cells
Representative western blots for total c-Raf and c-Raf phosphorylation at S338, S259,
S289/296/301 and for total ASK1 and ASK1 phosphorylation at S967, T845. Four separate
experiments were analyzed using cells from different donors, p>0.05.
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Figure 10. Effect of 6 hour exposures to 10 to 0.5 μM DBT on c-Raf and ASK1 in human NK
cells
A) Levels of c-Raf phosphorylated at S259 shown as fold change compared to control.
Values are mean ± S.D. from 4 separate experiments using cells from different donors
*p<0.05. B) Representative western blot for c-Raf phosphorylation at S259. C)
Representative western blots for total c-Raf and c-Raf phosphorylation at S338,
S289/296/301 and for total ASK1 and ASK1 phosphorylation at S967, T845. Four separate
experiments were analyzed using cells from different donors, p>0.05.
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